05.27.14
Positive clinical results for SinoVeda Canada Inc.’s supplement EffectiCal validate the formula’s benefits for bone health.
A 24-week double-blind, randomized comparative clinical trial in post-menopausal women found that EffectiCal, a supplement containing 300mg of calcium, was equally as effective as Pfizer’s Caltrate (600mg calcium) and vitamin D3 in measurements of bone formation and bone resorption. Additionally, subjects in this study who received EffectiCal had significantly fewer gastrointestinal side effects than those taking Caltrate.
“EffectiCal is a compelling supplementation option for individuals concerned about bone loss and osteoporosis. Compared to Caltrate, EffectiCal is a very dose-efficient product and has a very benign side effect profile,” stated Dr. Richard Fedorak, principal investigator and Professor of Medicine at the University of Alberta.
EffectiCal is a patented new form of multi-element calcium for the maintenance of bone health and reducing the risk of developing osteoporosis. Engineered to be more soluble in the intestine, EffectiCal provides more useable calcium per dose compared to existing calcium products. Since zinc and magnesium are often depleted in patients with low calcium intake, EffectiCal is supplemented with additional zinc and magnesium to maintain stable levels in the body.
For more information: http://sinoveda.com
A 24-week double-blind, randomized comparative clinical trial in post-menopausal women found that EffectiCal, a supplement containing 300mg of calcium, was equally as effective as Pfizer’s Caltrate (600mg calcium) and vitamin D3 in measurements of bone formation and bone resorption. Additionally, subjects in this study who received EffectiCal had significantly fewer gastrointestinal side effects than those taking Caltrate.
“EffectiCal is a compelling supplementation option for individuals concerned about bone loss and osteoporosis. Compared to Caltrate, EffectiCal is a very dose-efficient product and has a very benign side effect profile,” stated Dr. Richard Fedorak, principal investigator and Professor of Medicine at the University of Alberta.
EffectiCal is a patented new form of multi-element calcium for the maintenance of bone health and reducing the risk of developing osteoporosis. Engineered to be more soluble in the intestine, EffectiCal provides more useable calcium per dose compared to existing calcium products. Since zinc and magnesium are often depleted in patients with low calcium intake, EffectiCal is supplemented with additional zinc and magnesium to maintain stable levels in the body.
For more information: http://sinoveda.com
